NCT02475655: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02475655 |
|---|---|
| Title | A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 16, 2016 |
| Completion date | Feb. 18, 2018 |
| Required reporting date | Feb. 18, 2019, midnight |
| Actual reporting date | Feb. 14, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |